AI Verdict
KTB has stronger fundamentals based on our AI analysis.
KTTAW vs KTB Fundamental Comparison
| Metric | KTTAW | KTB |
|---|---|---|
| Revenue | $486,559.0 | $3.2B |
| Net Income | $-20.4M | $227.5M |
| Net Margin | -4,198.4% | 7.2% |
| ROE | -37.0% | 40.3% |
| ROA | -33.9% | 8.8% |
| Current Ratio | 11.35x | 1.82x |
| Debt/Equity | 0.00x | 2.02x |
| EPS | $-2.91 | $4.05 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
KTTAW vs KTB: Frequently Asked Questions
Is KTTAW or KTB a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), KTB has stronger fundamentals. KTTAW is rated SELL (72% confidence) while KTB is rated HOLD (68% confidence). This is not investment advice.
How does KTTAW compare to KTB fundamentally?
Pasithea Therapeutics Corp. has ROE of -37.0% vs Kontoor Brands, Inc.'s 40.3%. Net margins are -4,198.4% vs 7.2% respectively.
Which stock pays higher dividends, KTTAW or KTB?
KTTAW has a dividend yield of N/A or no dividend while KTB has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in KTTAW or KTB for long term?
For long-term investing, consider that KTTAW has SELL rating with 72% confidence, while KTB has HOLD rating with 68% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about KTTAW vs KTB?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For KTTAW vs KTB, the AI consensus favors KTB based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.